Assignee
HELIXMITH CO LTD
KR·13 granted patents·13 pending applications·1 citations·filing 2014–2023
Top patents by PatentIndex Score
26 records- 0174US2022362338A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 0272US2022296679A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2021·Application pending·0 cites
- 0371US11279769B2Anti-Sialyl Tn chimeric antigen receptorsHELIXMITH CO LTD·Filed 2016·Granted Mar 22, 2022·1 cites·25 claims
- 0468US10759841B2Gene therapy for diabetic neuropathy using an HGF isoformHELIXMITH CO LTD·Filed 2019·Granted Sep 1, 2020·0 cites·2 claims
- 0568US2019381138A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 0668US2026015628A1Aav vector optimized for intrathecal administration into which hepatocyte growth factor gene is introducedHELIXMITH CO LTD·Filed 2023·Application pending·0 cites
- 0767US2023218704A1Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 0866US2020354420A1Gene therapy for diabetic neuropathy using an hgf isoformHELIXMITH CO LTD·Filed 2020·Application pending·0 cites
- 0965US11541097B2Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2019·Granted Jan 3, 2023·0 cites·4 claims
- 1064USRE48404EHybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factorHELIXMITH CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·21 claims
- 1163US2024002462A1Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructsHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 1257US11554179B2Lyophilized pharmaceutical compositions for naked DNA gene therapyHELIXMITH CO LTD·Filed 2019·Granted Jan 17, 2023·0 cites·18 claims
- 1357US2020024323A1Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructsHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 1457US2022133827A1Herbal composition for preventing or treating benign prostatic hyperplasia diseaseHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 1556US2022023370A1Composition for preventing or treating metabolic bone diseases or menopausal symptomsHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 1655US11975039B2Herbal composition for treatment of attention deficit hyperactivity disorderHELIXMITH CO LTD·Filed 2019·Granted May 7, 2024·0 cites·9 claims
- 1755US11634728B2Adeno-associated virus (AAV) vector having hybrid HGF gene introduced theretoHELIXMITH CO LTD·Filed 2018·Granted Apr 25, 2023·0 cites·3 claims
- 1852US11559555B2Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2019·Granted Jan 24, 2023·0 cites·4 claims
- 1952US2025205154A1Liquid formulation pharmaceutical composition comprising plasmid dnaHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 2049US2022193171A1Pharmaceutical composition comprising mixture extract of coptis rhizome and schizonepeta tenuifolia as active ingredient for prevention or treatment of inflammatory bowel diseaseHELIXMITH CO LTD·Filed 2020·Application pending·0 cites
- 2145US12570719B2Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereofHELIXMITH CO LTD·Filed 2020·Granted Mar 10, 2026·0 cites·16 claims
- 2244US12180287B2Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereofHELIXMITH CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·5 claims
- 2344US10639351B2Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factorHELIXMITH CO LTD·Filed 2014·Granted May 5, 2020·0 cites·11 claims
- 2444US2020297790A1Herbal composition for preventing or treating benign prostatic hyperplasia diseaseHELIXMITH CO LTD·Filed 2018·Application pending·0 cites
- 2541US11510999B2Treatment of neuropathy with DNA constructs expressing IGF-1 isoformsHELIXMITH CO LTD·Filed 2019·Granted Nov 29, 2022·0 cites·15 claims
- 2636US11219667B2Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1AHELIXMITH CO LTD·Filed 2015·Granted Jan 11, 2022·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when HELIXMITH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →